ライフサイエンスコーパス: activator protein

1 tion the smaller regulons (bacteriorhodopsin-activator protein).

2 ase requires the action of a transcriptional activator protein.

3 sion by Cdk5 requires its binding to the p35 activator protein.

4 engagement with its cognate ATP-hydrolyzing activator protein.

5 terminal domain (BET) family of chromatin co-activator proteins.

6 may occur through increased levels of AR co-activator proteins.

7 ted by phosphorylation and by the binding of activator proteins.

8 RNA, the translation machinery and decapping activator proteins.

9 A polymerase II and upstream transcriptional activator proteins.

10 nal apparatus and for responsiveness to some activator proteins.

11 We demonstrate that activator protein 1 (AP-1) 'pioneers' the senescence enh

12 ted T-cells (NFAT) c1, whereas NF-kappaB and activator protein 1 (AP-1) activation were not adversely

13 nase, and phospho-cJun, as well as decreased activator protein 1 (AP-1) activity.

14 cription factors nuclear factor (NF)-kappaB, activator protein 1 (AP-1) and CCAAT/enhancer binding pr

15 We further linked JNK to RUNX1 through Activator Protein 1 (AP-1) and investigated the JNK-AP-1

16 evaluated by luciferase reporter assays for activator protein 1 (AP-1) and NF-kappaB.

17 ed HSPC specification by activating a unique activator protein 1 (AP-1) and runx1 transcription progr

18 nhancer of activated B cells (NF-kappaB) and activator protein 1 (AP-1) are transcription factors act

19 Radiation-induced AC gene transactivation by activator protein 1 (AP-1) binding on the proximal promo

20 c-Jun transcription factors, members of the activator protein 1 (AP-1) complex, form heterodimers an

21 K), phosphorylates c-Jun, a component of the activator protein 1 (AP-1) early response transcription

22 2-related factor 2 (Nrf2) and members of the activator protein 1 (AP-1) family of proteins.

23 restrict expression of JunB, a member of the activator protein 1 (AP-1) family of transcription facto

24 f interferon regulatory factor 4 (IRF4) with activator protein 1 (AP-1) family proteins and STAT3 in

25 ctor 7) are highly homologous members of the activator protein 1 (AP-1) family.

26 Activator protein 1 (AP-1) is a pivotal transcription fa

27 T: Activator protein 1 (AP-1) is a transcription factor tha

28 d to measure the effect of Smad3, MAPKs, and activator protein 1 (AP-1) on TGFbeta-mediated CCN3 prom

29 measure the effects of Smads 2, 3, and 7 and activator protein 1 (AP-1) on TGFbeta-mediated CTGF prom

30 factors nuclear factor kappaB (NFkappaB) and activator protein 1 (AP-1) regulate key proinflammatory

31 a cyclic AMP response element (CRE) and two activator protein 1 (AP-1) response elements in the muri

32 FAT), nuclear factor kappaB (NF-kappaB), and activator protein 1 (AP-1) to induce type 2 cytokines.

33 Hypoxia-inducible factor 1 (HIF-1) and activator protein 1 (AP-1) transcription complexes were

34 The actin-binding protein Ezrin and the activator protein 1 (AP-1) transcription factor are impl

35 Activation of the activator protein 1 (AP-1) transcription factor as well

36 ding enhancer element that contains multiple activator protein 1 (AP-1) transcription factor binding

37 d, and normal cellular FOS forms part of the activator protein 1 (AP-1) transcription factor complex,

38 JUN proto-oncogene, which forms part of the activator protein 1 (AP-1) transcription factor complex.

39 The Activator Protein 1 (AP-1) transcription factor subunit

40 K activation was required for the binding of activator protein 1 (AP-1) transcription factor to the M

41 Activator protein 1 (AP-1) transcription factors become

42 Following shear-flow exposure, six activator protein 1 (AP-1) transcripts (ATF4,JUNB,JUN,FO

43 The expression of the activator protein 1 (AP-1) was increased in lung tissues

44 Additionally, activator protein 1 (AP-1) was shown to be essential in

45 mponent of the transcription factor complex, activator protein 1 (AP-1), and promoted SIRT1 associati

46 We found that activator protein 1 (AP-1), Ets related gene (Erg) and G

47 ellular signal-regulated kinase 1/2 (Erk1/2)-activator protein 1 (AP-1), known collectively as the Ra

48 downstream target gene c-fos, a component of activator protein 1 (AP-1), that directly regulates epit

49 inal kinase (JNK), results in stimulation of activator protein 1 (AP-1), which promotes gene transcri

50 promoter and exhibit a strong enrichment for activator protein 1 (AP-1)-binding events, suggesting th

51 nt in mammals, shares functionally essential activator protein 1 (AP-1)-binding motifs, and responds

52 bital-responsive enhancer module (PREM), and activator protein 1 (AP-1-) -driven pathways.

53 ensus DNA sequence for transcription factors activator protein 1 (AP1) and specificity protein 1 (SP1

54 high-throughput sequencing, we identify the activator protein 1 (AP1) as a major partner for product

55 Deregulation of the activator protein 1 (AP1) family gene regulators has bee

56 The activator protein 1 (AP1) family transcription factor BA

57 extracellular signal-regulated kinase (Erk)-activator protein 1 (Ap1) pathway seems to mediate the e

58 ein (CHOP), X2-Box-binding protein 1 (XBP1), activator protein 1 (AP1), SMAD, CCAAT/enhancer-binding

59 we identified several functional NF-kappaB, activator protein 1 (AP1), STAT, and Smad DBS in the TSL

60 on in nonsteroidogenic cells, likely through activator protein 1 (AP1).

61 affect the ubiquitin-editing enzyme A20 and activator protein 1 (AP1).

62 sion that is mediated by DNA-bound NF-kappaB/activator protein 1 (AP1)/STAT3 activators and instrumen

63 Repressor activator protein 1 (RAP1) and telomeric repeat-binding

64 sphatase (PIP5Pase) interacts with repressor activator protein 1 (RAP1) in a multiprotein complex and

65 Repressor/activator protein 1 (RAP1) is a highly conserved telomer

66 Repressor activator protein 1 (Rap1) performs multiple vital cellu

67 ide direct evidence that the yeast repressor/activator protein 1 (Rap1), tightly bound to its consens

68 ct contact with the transactivator repressor activator protein 1 (Rap1).

69 TbPIP5Pase associates with repressor/activator protein 1 (TbRAP1), and their telomeric silenc

70 ytokine secretion, nuclear factor kappaB and activator protein 1 activation, mitogen-activated protei

71 by multiple transcription factors, including activator protein 1 and cAMP response element-binding pr

72 and miR-466l regulated transcription factors activator protein 1 and nuclear factor kappaB1 in miRNA

73 rosis factor alpha expression, and increased activator protein 1 and nuclear factor-kappaB transcript

74 d a trend for increased NF-AT, but decreased activator protein 1 and similar NF-kappaB, activity in C

75 late Mmp13 expression via the P2rx7/MAPK/ERK/activator protein 1 axis.

76 X1, PREP1 induces the expression of multiple activator protein 1 components including the proinvasive

77 LPS transcriptionally activates YAP through activator protein 1 in macrophages/KCs.

78 These results demonstrate that the c-Jun/activator protein 1 pathway is critical for maintaining

79 tivated the mitogen-activated protein kinase/activator protein 1 pathway, together with the inflammas

80 y signaling in addition to the classic c-Jun/activator protein 1 pathway, which provided the first ev

81 its target gene programmed cell death 4 and activator protein 1 pathway.

82 ceptor gamma agonist rosiglitazone decreased activator protein 1 promoter activity.

83 Our findings demonstrate that the JNK/activator protein 1 signaling pathway underlies the mela

84 ated by cyclooxygenase/nuclear factor-kappaB/activator protein 1 signaling pathways.

85 l-regulated kinase 1/2 pathway, involving an activator protein 1 site in MMP10 gene promoter.

86 binding of c-Fos and c-Jun to Mmp-9 promoter activator protein 1 sites.

87 Batf belongs to the activator protein 1 superfamily of basic leucine zipper

88 a highly conserved member of the multimeric activator protein 1 transcription factor complex and pla

89 suprabasal epidermis-specific inhibition of activator protein 1 transcription factor signaling.

90 stically, the LMO7 LIM domain interacts with activator protein 1 transcription factor subunits c-FOS

91 kappaB p65, and the nuclear translocation of activator protein 1 transcription factor.

92 ough serine 84 phosphorylation and promoting activator protein 1 transcription.

93 tion and nuclear factor of activated T cells/activator protein 1 transcriptional activity.

94 Although the c-Jun/activator protein 1 transcriptional factor regulates cel

95 AP-1 (activator protein 1) activity is strongly induced in res

96 ly conserved JNK/AP-1 (Jun N-terminal kinase/activator protein 1) and BMP (Bone Morphogenetic Protein

97 3beta (hepatocyte nuclear factor 3) and AP-1(activator protein 1) as proteins likely to be involved i

98 essibility were highly associated with AP-1 (activator protein 1) binding sites.

99 of GATA2 (GATA-binding protein 2) and AP-1 (activator protein 1) is significantly lower compared wit

100 the telomere-binding protein Rap1 (repressor activator protein 1) relocalizes to the upstream promote

101 g CD4(+) T cell activation: NF-kappaB, AP-1 (activator protein 1), and NFAT (nuclear factor of activa

102 ctivator, but not activator Rap1p (repressor-activator protein 1).

103 h the JNK pathway, reduced the activation of activator protein 1, and decreased the expression of MMP

104 g of transcription factors nuclear factor-Y, activator protein 1, and specificity protein 1, respecti

105 on of the inflammatory transcription factor, activator protein 1, but not NF-kappaB was observed.

106 Soluble LT also led to the activation of activator protein 1, whereas LT(+) vesicle IL-6 response

107 by COOH-truncated HBx was abolished when the activator protein 1-binding sites on the MMP10 promoter

108 r ubiquitination and degradation, disrupting activator protein 1-dependent TGF-beta autoinduction.

109 r; competition with the transcription factor activator protein 1; and reduced expression of histone d

110 ization of their regulators (Rap1 [repressor activator protein 1], Fhl1, Ifh1, Sfp1, and Hmo1), the t

111 ated with an increase in VEGF transcription, activator protein-1 (AP-1) activity, and JunB accumulati

112 Fos and Jun are components of activator protein-1 (AP-1) and play crucial roles in the

113 Previously, we implicated Akt and activator protein-1 (AP-1) as mediators of growth and ge

114 ent on nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1) binding and sensitive to phar

115 nsive changes following cryoinjury, and that activator protein-1 (AP-1) binding sites are the most hi

116 n addition, we found that MTA1/polymerase II/activator protein-1 (AP-1) co-activator complex interact

117 ntify a transcriptional program regulated by activator protein-1 (AP-1) complex, formed by c-Fos and

118 -/-)/Apc(Min/+) showed dramatic increases in activator protein-1 (AP-1) DNA binding, and SOCS2 overex

119 Here we show the activator protein-1 (AP-1) factor JunB is an essential r

120 The activator protein-1 (AP-1) family transcription factor,

121 n about the role of the transcription factor activator protein-1 (AP-1) in ABC DLBCL.

122 sensus binding site for transcription factor activator protein-1 (AP-1) is required for promoter acti

123 in a dose-dependent manner by activating the activator protein-1 (AP-1) member proteins c-FOS, JunD,

124 The levels of activator protein-1 (AP-1) mRNA and protein, as well as

125 Additionally, JunD but not JunB formed an activator protein-1 (AP-1) oligomeric complex to augment

126 Activator protein-1 (AP-1) regulates a wide range of cel

127 Activator protein-1 (AP-1) regulates diverse gene respon

128 0 and IL-12Rbeta2 via inhibition of the MAPK-activator protein-1 (AP-1) signaling pathway.

129 ven genes by attenuating the availability of activator protein-1 (AP-1) sites to Jun family signal-de

130 omoting redistribution of TAp73 from TP53 to activator protein-1 (AP-1) sites.

131 ctor-beta1 (TGF-beta1) signaling to activate activator protein-1 (AP-1) that in turn transcriptionall

132 to the pro-inflammatory transcription factor activator protein-1 (AP-1) through protein-protein inter

133 The proto-oncogene c-Jun is a component of activator protein-1 (AP-1) transcription factor complexe

134 ilitates latent infection by attenuating the activator protein-1 (AP-1) transcription factor subunit,

135 is an IDP that acts as a potentiator of the Activator Protein-1 (AP-1) transcription factor.

136 ranscriptional activation of c-Fos-dependent activator protein-1 (AP-1) via serum response factor (SR

137 e sulfate activates the transcription factor activator protein-1 (AP-1) via stimulation of transient

138 haracteristically contained motifs that bind activator protein-1 (AP-1), a pivotal regulator of infla

139 , such as nuclear factor kappaB (NF-kappaB), activator protein-1 (AP-1), and signal transduction and

140 rm of the immune response in the presence of activator protein-1 (AP-1), and T cell anergy/exhaustion

141 The transcription factor, activator protein-1 (AP-1), binds to cognate DNA under r

142 cer of activated B cells (NF-kappaB), STAT3, activator protein-1 (AP-1), hypoxia-inducible factor-1 (

143 e-induced promoter activity of NF-kappaB and activator protein-1 (AP-1), indicating that NF-kappaB an

144 which is a component of transcription factor activator protein-1 (AP-1), to the promoter region of mi

145 e wg expression through transcription factor activator protein-1 (AP-1).

146 e transcription factors NF-kappaB itself and activator protein-1 (AP-1).

147 oblast differentiation via the activation of activator protein-1 (AP-1).

148 tion factors such as nuclear factor B (NFB), activator protein-1 (AP1) and heat shock factor 1 (HSF1)

149 ressed, IRF4 unexpectedly can cooperate with activator protein-1 (AP1) complexes to bind to AP1-IRF4

150 kappaB) and epidermal growth factor receptor-activator protein-1 (EGFR-AP1) pathways are often co-act

151 ediated mitogen-activated protein kinase and activator protein-1 activation, and epithelial to mesenc

152 phosphorylation is critical for controlling activator protein-1 activity, which is a major driver in

153 dose, many of which are under the control of activator protein-1 and ERK signaling.

154 otein-1 (GRIP1), GR tethers to the DNA-bound activator protein-1 and NF-kappaB and represses transcri

155 9 in vitro, which required activation of the activator protein-1 and nuclear factor-kappaB signaling

156 ivation was specific, inasmuch as binding of activator protein-1 and octameric transcription factor 1

157 tant synapses, c-Jun N-terminal kinase (JNK)/activator protein-1 and TGF-beta signaling were overacti

158 ogic events through the transcription factor activator protein-1 and transcription-independent contro

159 atin immunoprecipitation (ChIP), we detected activator protein-1 binding within an evolutionarily con

160 otein-1 reporter activity, but activation of activator protein-1 by the three SLK mutants was ineffec

161 ivated involucrin promoter activity, nuclear activator protein-1 factor accumulation and binding to D

162 ncreases the expression of ET(A) R, OBRb and activator protein-1 in HSCs.

163 ion of mitogen-activated protein kinases and activator protein-1 in myofibers of mdx mice.

164 AR-small interfering RNA or treated with the activator protein-1 inhibitor SR-11302 [3-methyl-7-(4-me

165 kinase 1/2 mitogen-activated protein kinase/activator protein-1 pathway activation.

166 Similarly, SLK WT stimulated activator protein-1 reporter activity, but activation of

167 ERbeta-dependent retardation of migration of activator protein-1 response elements in EMSA.

168 xpression is up-regulated by ROS through the activator protein-1 signaling pathway and promotes cell

169 d transcriptional activation of the relevant activator protein-1 site in the human TGFbeta1 promoter.

170 enhanced c-Fos/c-Jun binding to the proximal activator protein-1 site of the StAR promoter in HPAECs,

171 Ser(63) and Ser(73), resulting in increased activator protein-1 transactivation.

172 IL-1beta signaling converges upon the activator protein-1 transcription factors, which have be

173 by Cav1 knockdown to increased expression of activator protein-1 transcriptional targets, including c

174 receptor 1) was identified as a novel c-Fos/activator protein-1(AP-1)-regulated gene.

175 V6 expression is through EGR1-mediated AP-1 (activator protein-1) activity and that the EGR1- and AP-

176 oto-oncogene subunit), a member of the AP-1 (activator protein-1) family of transcription factors, is

177 rotein partner of DeltaFosB binding to AP-1 (activator protein-1) sites of genes, remained unchanged

178 ncreased SRF phosphorylation activates AP-1 (activator protein-1)-dependent enhancers that direct myo

179 s binding to transcription factors NFkappaB, Activator Protein-1, and CCAAT/enhancer-binding protein

180 55,212-2 acts via PPARalpha to activate JNK, activator protein-1, and positive regulatory domain IV t

181 possibly because of decreased activation of activator protein-1, compared with control cells overexp

182 ing from GPCRs and RhoA to the regulation of activator protein-1, NFkappaB (nuclear factor kappa-ligh

183 matory transcription control pathways (i.e., activator protein-1, nuclear factor-kappaB) in response

184 tor, endothelin-1 type A receptor (ET(A) R), activator protein-1, transforming growth factor beta (TG

185 ions involving several signaling modulators, activator protein-1-dependent gene expression remains hi

186 the nuclear factor of activated T cell- and activator protein-1-dependent signaling pathways, which

187 y phosphorylation of c-Jun and activation of activator protein-1-dependent transcription.

188 RK2), in turn leading to inhibition of c-Jun/activator protein-1-dependent transcriptional activity.

189 loproteinases driving the induction of c-Jun/activator protein-1.

190 The Transcription Factor Activator Protein 2 (Tfap2) was duplicated in the chorda

191 zfh-2 is controlled by the Drosophila activator protein 2 gene and regulates the late expressi

192 (betaAR), cAMP and the transcription factor activator protein-2 (AP-2) are contributors to the Abeta

193 (VSMCs), resulting in the phosphorylation of activator protein 2alpha (AP-2alpha) and consequent matr

194 ectly responsive to the transcription factor activator protein 2C (TFAP2C).

195 Transcription Factor Activator Protein 2gamma (TFAP2C, AP-2gamma) governs lum

196 Like native transcriptional activator proteins, an ATA must minimally contain a DNA-

197 nisms underlying the function of KLF14 as an activator protein and novel regulator of lipid signaling

198 g an auto-regulatory loop involving the YdeO activator protein and novel roles for the PhoP protein.

199 We used sdsB1 activator protein and SDS-responsive promoter of sdsA1 g

200 nucleosome-remodeling complexes recruited by activator proteins and elongating RNA polymerase II.

201 transcription factors, TFIIS, the Pho4 gene activator protein, and the SAGA, SWI/SNF, and Mediator c

202 t, including the short-lived activity of the activator protein, and the time-of-day when induction an

203 genes transcribed by promoters containing an activator protein (AP)-1 binding site were significantly

204 ylation of c-Fos and formation of a specific activator protein (AP)-1 complex.

205 endothelial NF-kappaB pathway activated the activator protein (AP)-1 pathway (NF-kappaB-to-AP-1 swit

206 lar growth and potentiate transactivation of activator protein (AP)-1 target genes such as cyclin D1.

207 in-enhancer of activated B cells (NF-kB) and activator protein (AP)-1 through regulation of their tar

208 fferentiation, we cloned SARI (suppressor of activator protein (AP)-1, regulated by interferon (IFN))

209 Overexpression of the activator protein (AP)-2gamma transcription factor in br

210 EVI1-occupied genes contain linked EVI1 and activator protein (AP)1 DNA binding sites, and this find

211 -response element (HRE)-1, HRE-2, and distal activator protein (AP-1) sites.

212 opy map of APC/C in complex with the Cdh1 co-activator protein (APC/C(Cdh1)) bound to a D-box peptide

213 In the presence of the LPL activator protein apoC-II, more of apoC-I or apoC-III wa

214 Its activator proteins are members of the AAA+ superfamily a

215 C/C-Cdh1 through phosphorylation of the Cdh1 activator protein at multiple sites.

216 ned primarily by the genomic distribution of activator proteins at enhancers and promoters.

217 transcription in bacteria requires specific activator proteins, bacterial enhancer binding protein (

218 ced ITGA5 promoter activity through an AP-1 (activator protein)-binding site proximal to the transcri

219 like Wp, interacts with the B cell-specific activator protein BSAP/Pax5.

220 Pax5/B cell lineage specific activator protein (BSAP) is a B lineage-specific regulat

221 the first time that B-cell lineage specific activator protein (BSAP), also known as paired box 5 (PA

222 These GAF domain dimers regulate sigma(54) activator proteins by holding the ATPase domains in an i

223 tested the hypothesis that the Ca2+-binding activator protein calmodulin (CaM) is the primary decode

224 ed gene regulation and another way that this activator protein can repress protein expression.

225 The catabolite activator protein (CAP) of Escherichia coli is an exempl

226 of DNA to several variants of the catabolite activator protein (CAP) that differentially populate the

227 x comprising the Escherichia coli catabolite activator protein (CAP), RNA polymerase holoenzyme (RNAP

228 t to a challenging test case: the catabolite activator protein (CAP).

229 TAP) [homolog of Escherichia coli catabolite activator protein (CAP)], T. thermophilus RNAP sigma(A)

230 osidase and beta-hexosaminidases, and of GM2-activator protein, cause infantile (with tetraparesis, d

231 checkpoint proteins Mad2, Mad3 and APC/C co-activator protein Cdc20), we reveal the molecular basis

232 by this ubiquitin ligase depends on related activator proteins, Cdc20 and Cdh1, which bind and activ

233 CdhA, the A. nidulans homologue of the APC/C activator protein Cdh1, in gamma-tubulin-dependent inact

234 of CO rebinding to carbon monoxide oxidation activator protein (ChCooA) are measured over a wide temp

235 hibitor with enhanced affinity for circadian activator proteins Clock and Bmal1.

236 The Sum1 repressor and Ndt80 activator proteins control middle promoters by binding t

237 of the heme in the carbon monoxide oxidation activator protein (CooA) from the thermophilic anaerobic

238 We show how mRNA substrate and the activator proteins Dcp1 and Edc1 influence the dynamic e

239 e transcription factor BSAP (B-cell-specific activator protein) directly interacts with Dleu2, the ho

240 ted for p150(Glued), a subunit of the dynein activator protein dynactin.

241 inhibitor protein (IRP) binding and increase activator protein (eIF4F) binding identifies IRE-RNA as

242 though this process is known to involve a co-activator protein (either Cdc20 or Cdh1) together with c

243 transcriptional regulator Class II MHC trans-activator protein expressed by a subset of insulin(+)CD6

244 inhibited through direct binding of the anti-activator protein ExsD.

245 by competing with the forkhead transcription activator protein Fkh2p for binding to Mcm1p through pro

246 RP2 has been considered to be a GTPase activator protein for ARL3 and to play a role in the tra

247 Saposin B (Sap B) is an essential activator protein for arylsulfatase A in the hydrolysis

248 in LDCVs.SIGNIFICANCE STATEMENT The calcium activator protein for secretion (CAPS) promotes and stab

249 We studied the role of calcium-activator protein for secretion (CAPS) proteins in neuro

250 Calcium-dependent activator protein for secretion 1 (CAPS1) is a multidoma

251 ns with known roles (CAPS [calcium-dependent activator protein for secretion 1], Munc13-2, RIM1, and

252 Genetic loss of CAPS1 (aka calcium-dependent activator protein for secretion, CADPS), a vesicle-bound

253 etween short peptide motifs in repressor and activator proteins for interaction with a common binding

254 The calcium-dependent activator proteins for secretion (CAPS) are priming fact

255 activity and/or ability to interact with the activator proteins, GCAPs.

256 The GM2 activator protein (GM2AP) is an accessory protein requir

257 ower DNA packaging velocity, and required an activator protein, gp16 for rapid firing of ATPases.

258 -dependent nuclear transcription factor heme activator protein (Hap1p).

259 urs by interactions between a self-enhancing activator protein, HetR, and a diffusible pentapeptide i

260 scription factors, including four catabolite activator protein homologues.

261 Ca(2+)-dependent activator protein in secretion 1 (CAPS-1; CADPS/UNC31) a

262 ression levels of the underlying ligand-free activator proteins in the device.

263 Overexpression of these activator proteins in vivo increases the abundance of GL

264 In addition, the CapA1 activator protein interacts with and cleaves lipid-linke

265 ed signaling via GLP-1 receptor or the CREBP activator protein kinase A thus offers a way to rescue i

266 The liver-enriched transcriptional activator protein (LAP) isoform of CCAAT/enhancer bindin

267 Similarly, CEBPB-liver-enriched activator protein (LAP) isoform overexpression suppresse

268 the key control region and indicate that an activator protein modulates leukotoxin transcription.

269 e promoter, P(m), requires the phage-encoded activator protein Mor and the bacterial RNA polymerase.

270 -bound sites by the SAP domain-containing co-activator protein myocardin, and we show that paired sit

271 netically removing PTG, a glycogen synthesis activator protein, nearly completely eliminates Lafora b

272 Bid is a proapopotic activator protein of the Bcl-2 family that plays a pivot

273 Activator protein one (AP1) (jun/fos) factors comprise a

274 e typically marked by the co-transcriptional activator protein p300 or by groups of cell-expressed tr

275 oligomers were formed in the presence of the activator protein p7/p15Bid.

276 ransactivator under the control of the liver activator protein promotor with transgenic mice carrying

277 The network of activator protein-protein interactions (PPIs) that under

278 The activator protein PspF was not involved in the PspA-TatA

279 mutations in PURA, encoding transcriptional activator protein Pur-alpha, within the critical region.

280 es cerevisiae (Sc), the generalist repressor-activator protein Rap1 now directs the Ifh1-Fhl1 module

281 ng factors, or OGG1 binds OG and facilitates activator protein recruitment.

282 usively by the replication and transcription activator protein RTA (open reading frame 50 [ORF50] gen

283 cs, which are composed of human sphingolipid activator protein saposin A and a small number of phosph

284 at acidic pH values by cationic sphingolipid activator proteins (SAPs), presenting lipids to their re

285 ely accepted model, the steroid receptor RNA activator protein (SRA protein; SRAP) modulates the tran

286 ning 1 (ZNHIT1) to block Snf2-related CREBBP activator protein (SRCAP) activity and prevents the depo

287 ce and chemistry of the motifs that bind the activator protein SRSF1, but it is not improved by incre

288 en complexes requires the ATPase activity of activator proteins that bind remotely upstream of the tr

289 ription by RNA polymerase II is regulated by activator proteins that recruit the coactivator complexe

290 f the ATPase site in an AAA+ transcriptional activator protein, the phage shock protein F (PspF), by

291 though there is considerable focus on kinase activator proteins, the importance of specific T-loop ph

292 its require the action of a 'transcriptional activator' protein to open the promoter and initiate tra

293 omote the proteasomal degradation of the ATR activator protein topoisomerase-IIbeta-binding protein 1

294 ression is controlled by the transcriptional activator protein ToxT.

295 ive conformation and disrupts binding to its activator protein TPX2, which impairs Aurora A localizat

296 respiratory growth and regulated by the heme activator protein transcriptional activation complex.

297 omplement of a gene encoding a transcription activator protein (TrAP).

298 comprises Thermus thermophilus transcription activator protein TTHB099 (TAP) [homolog of Escherichia

299 The activator proteins undergo regulated assembly from inact

300 controls growth through a transcriptional co-activator protein, Yorkie.